Cure for AIDS Act of 2013

Bill: 113-hr-3630
Sponsor: full_name: Rep. Himes, James A. [D-CT-4]
Introduced: 2013-12-02
Policy area: Health
Subjects: Drug therapy

HIV/AIDS

Health programs administration and funding

Immunology and vaccination

Medical research

Military medicine

Research administration and funding
Latest action: action_date: 2014-01-24
text: Referred to the Subcommittee on Military Personnel.

Summaries:
action_date: 2013-12-02
action_desc: Introduced in House
text: <p>Cure for AIDS Act of 2013 - Directs the Secretary of Defense (DOD), through the Congressionally Directed Medical Research Program, to establish and support an accelerated research program dedicated to discovering a cure for HIV/AIDS. </p> <p>Instructs the Secretary to collaborate with the Director of the National Institutes of Health (NIH), the Director of the National Institute of Allergy and Infectious Diseases, and other appropriate federal agencies. </p> <p>Requires the Secretary to: (1) ensure that such research is highly targeted, (2) coordinate with at least one eligible nonprofit entity, and (3) ensure that the responsibilities of the non-profit entity include partnering with the Secretary in establishing research priorities.</p>

tv_txt: I 113th CONGRESS 1st Session H. R. 3630 IN THE HOUSE OF REPRESENTATIVES December 2, 2013 Mr. Himes (for himself, Ms. Lee of California , and Ms. Wilson of Florida ) introduced the following bill; which was referred to the Committee on Armed Services , and in addition to the Committee on Energy and Commerce , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To establish a research program under the Congressionally Directed Medical Research Program of the Department of Defense to discover a cure for HIV/AIDS.

1. Short title This Act may be cited as the Cure for AIDS Act of 2013 . 2. Sense of Congress; findings (a) Sense of Congress It is the sense of Congress that— (1) finding a cure is essential to ending the AIDS epidemic in the United States and globally; (2) AIDS treatment has saved millions of lives and also makes it much less likely that HIV infection will be passed to a partner; (3) access to AIDS treatment in the United States and globally needs to continue to be expanded but AIDS treatment is not a cure and not the ultimate solution for the tens of millions of people living with HIV/AIDS; (4) the National Institutes of Health is the leading health research organization in the world and has dedicated millions of dollars to AIDS cure research; (5) to accelerate AIDS cure research and product development, it is becoming increasingly important to invest in areas that can complement the essential role of the National Institutes of Health; and (6) a cure will save hundreds of millions of dollars in spending and have a powerful positive economic impact globally. (b) Findings Congress finds the following: (1) It is estimated that in 2012 roughly 35,300,000 people were living with HIV/AIDS worldwide. (2) In the United States, 1,200,000 Americans are estimated to be infected with the virus. (3) Every 9.5 minutes, a citizen of the United States becomes infected with HIV. Roughly 2,700,000 individuals, including 390,000 children, became newly infected with HIV in 2010 alone. (4) In fiscal year 2012, the Federal Government spent $27,700,000,000 on HIV/AIDS, the largest component being services and treatment for people living with HIV/AIDS in the United States at a cost of $15,600,000,000. The average lifetime cost of HIV treatment is estimated to be $367,134 per person. (5) In the last two years, discoveries have led to growing optimism in the scientific community that a cure for AIDS can be found. The eradication of HIV from the body of one individual in Germany has led many scientific leaders to believe that curing AIDS is now possible. Leading researchers believe we are now at the cutting edge of scientific discovery for an AIDS cure with a range of novel approaches being explored, including stem cells, gene therapy, medications, and immune response modifications, such as therapeutic vaccines. 3. Establishment of HIV/AIDS Congressionally Directed Medical Research Program (a) Establishment of research program (1) In general The Secretary of Defense, acting through the Congressionally Directed Medical Research Program, shall establish and support an accelerated research program dedicated to the discovery of a cure for HIV/AIDS. (2) Administration The Secretary shall carry out the research program established under paragraph (1) in collaboration with— (A) the Director of the National Institutes of Health; (B) the Director of the National Institute of Allergy and Infectious Diseases; and (C) any head of a Federal agency that the Secretary determines appropriate. (b) Scope To provide the basis for developing a cure for HIV/AIDS, the Secretary shall ensure that research conducted under subsection (a)(1) is highly targeted to address the following scientific questions and priorities: (1) How HIV persists despite antiretroviral therapy. (2) Where HIV persists beyond the reach of antiretroviral therapy. (3) Whether ongoing attempts of the immune system to clear the infection actually hinders the ability of the medical community to cure infected individuals. (4) Why the immune system reduces but does not eliminate levels of the virus. (5) How to measure ultra-low levels of the virus in the body of an infected individual. (6) Identifying and testing interventions, such as drugs, that may eliminate the virus from infected individuals. (7) Identifying and testing interventions, such as vaccines, that may help an infected individual permanently control the virus without antiretroviral therapy. (c) Assistance by nonprofit entities (1) Coordination In carrying out the research program established under subsection (a)(1), the Secretary shall coordinate with at least one eligible nonprofit entity— (A) whose primary mission is ending the AIDS epidemic through innovative research; and (B) that has experience carrying out programs dedicated to AIDS cure research. (2) Responsibilities The Secretary shall ensure that the responsibilities of a nonprofit entity selected under paragraph (1) include partnering with the Secretary to establish research priorities for peer-reviewed funded research pursuant to subsection (b). (d) Annual reports In each annual report on the Congressionally Directed Medical Research Program that the Secretary submits to Congress, the Secretary shall include information on the progress of the research program established under subsection (a)(1). (e) Authorization of appropriations There is authorized to be appropriated to carry out this section $20,000,000 for each of fiscal years 2014 through 2018.